New psilocybin study shows promising results for treatment‑resistant depression

Posted by student_rational in Research & News - 2 points, 0 comments.

I just finished reading a short report in the Journal of Clinical Psychopharmacology that followed 12 people with treatment‑resistant depression who received a single 20‑ahaere session of psilocybin (10‑30 mg). The authors found that, at 2‑weeks post‑dose, almost all participants had a clinically meaningful drop in depression scores and that the effect lingered to 6 weeks. It struck me because the study sticks to the “one‑to‑few supervised sessions” model that people talk about on Reddit, and it’s not a mega‑budget trial. I’m not saying this is a cure tinder‑fire, but the fact that the benefit seems to hold for months with no maintenance doses is exciting. The paper also notes that participants reported intense anxiety during the trip, which mirrors the side‑effect list on the /peptides/psilocybin page, showing how important guidance is.

I’m curious: for those who’ve looked into psilocybin as an adjunct in therapy, did you notice a similar lasting effect? What safety net do you think is essential for a first‑time session?

Community discussion - research and educational context only. Not medical advice.